Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

604 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Third dose of SARS-CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients.
Montalbano M, Piccolo P, Lionetti R, Visco-Comandini U, Agrati C, Grassi G, Meschi S, Matusali G, Conte F, Angelone F, Ettorre GM, Guglielmo N, Maggi F, Francalancia M, Mereu T, Puro V, Girardi E, D'Offizi G. Montalbano M, et al. Among authors: girardi e. Liver Int. 2023 May;43(5):1120-1125. doi: 10.1111/liv.15557. Epub 2023 Apr 1. Liver Int. 2023. PMID: 36929682
Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022.
Novazzi F, Giombini E, Rueca M, Baj A, Fabeni L, Genoni A, Ferrante FD, Gramigna G, Gruber CEM, Boutahar S, Minosse C, Butera O, Pasciuta R, Focosi D, Colombo A, Antinori A, Girardi E, Vaia F, Maggi F. Novazzi F, et al. Among authors: girardi e. Euro Surveill. 2023 Jan;28(2):2300008. doi: 10.2807/1560-7917.ES.2023.28.2.2300008. Euro Surveill. 2023. PMID: 36695479 Free PMC article.
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.
Rescigno M, Agrati C, Salvarani C, Giannarelli D, Costantini M, Mantovani A, Massafra R, Zinzani PL, Morrone A, Notari S, Matusali G, Pinter GL, Uccelli A, Ciliberto G, Baldanti F, Locatelli F, Silvestris N, Sinno V, Turola E, Lupo-Stanghellini MT, Apolone G; VAX4FRAIL study Group. Rescigno M, et al. Front Immunol. 2023 Jan 27;14:1104124. doi: 10.3389/fimmu.2023.1104124. eCollection 2023. Front Immunol. 2023. PMID: 36776853 Free PMC article.
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort.
d'Arminio Monforte A, Tavelli A, Rossotti R, Gagliardini R, Saracino A, Lo Caputo S, Sala M, Quiros-Roldan E, Mussini C, Girardi E, Cozzi-Lepri A, Antinori A, Puoti M; NoCo Study of the Icona cohort. d'Arminio Monforte A, et al. Among authors: girardi e. Liver Int. 2023 Oct;43(10):2130-2141. doi: 10.1111/liv.15700. Epub 2023 Aug 31. Liver Int. 2023. PMID: 37649460 Free article.
Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications.
Pinnetti C, Cimini E, Mazzotta V, Matusali G, Vergori A, Mondi A, Rueca M, Batzella S, Tartaglia E, Bettini A, Notari S, Rubino M, Tempestilli M, Pareo C, Falasca L, Del Nonno F, Scarabello A, Camici M, Gagliardini R, Girardi E, Vaia F, Maggi F, Agrati C, Antinori A. Pinnetti C, et al. Among authors: girardi e. Lancet Infect Dis. 2024 Feb;24(2):e127-e135. doi: 10.1016/S1473-3099(23)00482-6. Epub 2023 Sep 28. Lancet Infect Dis. 2024. PMID: 37778364 Review.
Outbreaks of autochthonous Dengue in Lazio region, Italy, August to September 2023: preliminary investigation.
De Carli G, Carletti F, Spaziante M, Gruber CEM, Rueca M, Spezia PG, Vantaggio V, Barca A, De Liberato C, Romiti F, Scicluna MT, Vaglio S, Feccia M, Di Rosa E, Gianzi FP, Giambi C, Scognamiglio P, Nicastri E, Girardi E, Maggi F, Vairo F; Lazio Dengue Outbreak Group; Lazio dengue Outbreak Group. De Carli G, et al. Among authors: girardi e. Euro Surveill. 2023 Nov;28(44):2300552. doi: 10.2807/1560-7917.ES.2023.28.44.2300552. Euro Surveill. 2023. PMID: 37917030 Free PMC article.
COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
Messina F, Giombini E, Agrati C, Vairo F, Ascoli Bartoli T, Al Moghazi S, Piacentini M, Locatelli F, Kobinger G, Maeurer M, Zumla A, Capobianchi MR, Lauria FN, Ippolito G; COVID 19 INMI Network Medicine for IDs Study Group. Messina F, et al. J Transl Med. 2020 Jun 10;18(1):233. doi: 10.1186/s12967-020-02405-w. J Transl Med. 2020. PMID: 32522207 Free PMC article.
604 results